Teratogen update: Angiotensin‐converting enzyme inhibitors¶
Barr. (1994). Teratogen update: Angiotensin‐converting enzyme inhibitors: Angiotensin‐converting enzyme inhibitors. Teratology.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Domain-specific¶
- Contraindication
- The same mechanism (angiotensin-converting-enzyme blockade) that helps the typical patient impairs the fetal renin-angiotensin system, causing reduced fetal renal perfusion, oligohydramnios, skull ossification defects, and neonatal renal failure
This sourceThe canonical description of ACE-inhibitor fetopathy: blockade of the fetal renin-angiotensin system produces fetal hypotension and renal hypoperfusion, with oligohydramnios, neonatal renal failure and hypocalvaria following — a second- and third-trimester effect, distinct from the first-trimester malformation question.
- The same mechanism (angiotensin-converting-enzyme blockade) that helps the typical patient impairs the fetal renin-angiotensin system, causing reduced fetal renal perfusion, oligohydramnios, skull ossification defects, and neonatal renal failure
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:419239a0ced0 · see in the full table